Crossmark

Gelsolin (GSN) as a key regulator in estrogen receptor-positive breast cancer: implications for prognosis, chemotherapy sensitivity, and immune infiltration

Crossref DOI link: https://doi.org/10.1007/s12672-025-03128-4

Published Online: 2025-07-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lv, Mian

Wang, Huiling

Feng, Guanqing

Nong, Qingxiao

Tao, Shouwen

Ma, Yanfei

Fang, Dalang
Funding

Funding for this research was provided by:

The Guangxi Zhuang Autonomous Region Health Committee Self-financing Scientific Research Subject (Z-A20231153)
License Information

Text and Data Mining valid from 2025-07-09

Version of Record valid from 2025-07-09
More Information

Article History

Received: 27 February 2025

Accepted: 1 July 2025

First Online: 9 July 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below